WeVote

Bill

Bill

H 4346

An Act to ensure access to prescription medications

194th Legislature (2025-2026) Introduced by Alan Silvia

Massachusetts bill to improve prescription medication access through regulatory or financial mechanisms, currently under Health Care Financing Committee review.

Reporting date extended to Friday, July 31, 2026
0
WeVote Research Nonpartisan
Bill Summary · H 4346

Legislative bill overview

H 4346 aims to improve access to prescription medications in Massachusetts by addressing barriers to medication affordability and availability. The bill was reported favorably from the Financial Services Committee and has been referred to the Health Care Financing Committee for further consideration. The specific mechanisms for ensuring access appear to involve regulatory or financial provisions under review.

Why is this important

Prescription medication access directly affects public health outcomes, particularly for low-income residents and those with chronic conditions. Medication cost and availability barriers can lead to worse health outcomes, increased hospitalizations, and broader economic impacts on the state's healthcare system.

Potential points of contention

  • Cost allocation: Determining who bears the financial burden of expanded access—insurers, pharmaceutical companies, or state budgets—will likely be contentious
  • Scope of coverage: Disagreement may emerge over which medications qualify for access protections and whether all demographics are equally covered
  • Implementation feasibility: Questions about whether proposed mechanisms can effectively reach underserved populations without creating bureaucratic obstacles or unintended market effects

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.